Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Mallinckrodt
US Army
Argus Health
US Department of Justice
Covington

Generated: August 18, 2019

DrugPatentWatch Database Preview

Patent: 8,119,129

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,119,129
Title:Combination of anti-CTLA4 antibody with dasatinib for the treatment of proliferative diseases
Abstract: Compositions and methods are disclosed which are useful of the treatment and prevention of proliferative disorders.
Inventor(s): Jure-Kunkel; Maria (Plainsboro, NJ), Lee; Francis Y. (Yardley, PA)
Assignee: Bristol-Myers Squibb Company (Princeton, NJ)
Application Number:12/462,168
Patent Claims:see list of patent claims

Details for Patent 8,119,129

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Bristol Myers Squibb YERVOY ipilimumab INJECTABLE; INJECTION 125377 001 2011-03-25 ➤ Sign Up Bristol-Myers Squibb Company (Princeton, NJ) 2028-08-01 RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
UBS
Cantor Fitzgerald
Chinese Patent Office
Farmers Insurance
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.